NCT03143335

Brief Summary

The purpose of this study is to examine different outcomes of breast reconstruction in women who are treated for breast cancer with skin sparing mastectomy and subsequently a primary implant based reconstruction by one of two different techniques with either a pre- or retropectoral placement of the implant. The main objective of the study is to establish whether one of these techniques may result in a superior outcome and thus should be recommended as first choice treatment rather than the other.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
2 countries

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 8, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

August 29, 2019

Status Verified

August 1, 2019

Enrollment Period

2.9 years

First QC Date

May 1, 2017

Last Update Submit

August 27, 2019

Conditions

Keywords

Breast; Reconstruction; BAD; Implant; ADM

Outcome Measures

Primary Outcomes (1)

  • Breast animation deformity

    Breast animation deformity (BAD) is one of the more unpleasant cosmetic results that can be seen after breast reconstruction with a retropectoral placed implant. The degree of breast distortion will be evaluated by two experienced plastic surgeons and classified according to the published classification by Spear S. Because the degree of breast distortion will be the primary outcome measure of this randomised trial, the sample size will be based on assumptions regarding the grade of distortion between groups. For this purpose, the distortion will be divided into two groups: 1) Severe distortion containing degree 3 and 4 and 2) Moderate distortion containing degree 1 and 2. In bilateral cases the most severe side will be the one used for comparison

    12 months

Secondary Outcomes (1)

  • Shoulder function

    3 and 12 months

Other Outcomes (8)

  • Quality of Life

    12 months

  • Postoperative pain

    3 months

  • Postoperative complications

    3 months

  • +5 more other outcomes

Study Arms (2)

Retropectoral immediate breast reconstruction

ACTIVE COMPARATOR

Participants are randomized to immediate breast reconstruction with the implant placed retropectoral.

Procedure: Retropectoral immediate breast reconstruction

Prepectoral immediate breast reconstruction

ACTIVE COMPARATOR

Participants are randomized to direct to immediate breast reconstruction with the implant placed prepectoral using acellular dermal matrix for support.

Procedure: Prepectoral immediate breast reconstruction

Interventions

Immediate reconstruction with the implant placed in a standard fashion, i.e. retropectoral in combination with an acellular dermal matrix.

Retropectoral immediate breast reconstruction

Immediate breast reconstruction with the implant placed prepectoral supported by acellular dermal matrix alone.

Prepectoral immediate breast reconstruction

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women over 18 years referred to the Department of plastic surgery, Odense University Hospital, Lillebaelt Hospital Vejle, Denmark or Telemark Hospital, Skien, Norway between January 2017 and July 2018, who are found eligible for immediate breast reconstruction.

You may not qualify if:

  • Dementia that makes it impossible to obtain informed consent
  • Non-Danish speaking patients from whom informed consent cannot be obtained by interpreter
  • Tobacco users
  • Women with known hypertension treated with more than one drug
  • Women who had pre-surgical radiation therapy.
  • Women planned to have postsurgical radiation therapy.
  • BMI above 32 or below 22
  • However, the final decision relies on sufficient thickness of the skin flaps after mastectomy prior to immediate reconstruction.
  • Invited patient will receive both oral and written participant information after which there will be as many days for reflection as the treatment guaranty for cancer allows.
  • Patients considering participation will be invited for a second consultation where written informed consent will be obtained from all who accept the invitation. Randomization will be performed during surgery, prior to reconstruction. Patients who do not wish to participate will be reconstruction with the implant placed retropectoral.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Odense University Hospital

Odense, 5000, Denmark

Location

Lillebaelt Hospital Vejle

Vejle, 7100, Denmark

Location

Telemark Hospital

Skien, 3710, Norway

Location

Related Publications (1)

  • Dyrberg DL, Gunnarsson GL, Bille C, Sorensen JA, Thomsen JB. Direct-to-Implant Extracellular Matrix Hammock-based Breast Reconstruction; Prepectoral or Subpectoral? Trials. 2020 Feb 10;21(1):160. doi: 10.1186/s13063-020-4125-6.

Study Officials

  • Jørn Bo JB Thomsen, MD, PhD

    Center Hospital Vejle, Institute of Regional Health Research, University of Southern Denmark

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

May 1, 2017

First Posted

May 8, 2017

Study Start

May 1, 2017

Primary Completion

April 1, 2020

Study Completion

May 1, 2020

Last Updated

August 29, 2019

Record last verified: 2019-08

Locations